Twist Bioscience Balance Sheet
NASDAQ: TWSTHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Twist Bioscience financial position
At the end of fiscal 2025, Twist Bioscience reported total assets of $641.9 million, up 4.5% from a year earlier against total liabilities of $168.9 million. Shareholders' equity stood at $473.0 million, or 73.7% of assets. The company held $183.0 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 3.64, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Twist Bioscience balance sheet (annual)
| Fiscal year (USD) | FY 20252025-09-30 | FY 20242024-09-30 | FY 20232023-09-30 | FY 20222022-09-30 | FY 20212021-09-30 | FY 20202020-09-30 | FY 20192019-09-30 | FY 20182018-09-30 | FY 20172017-09-30 |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 183.05M | 226.32M | 286.47M | 378.69M | 465.83M | 93.67M | 46.73M | 80.76M | 31.23M |
| Short-Term Investments | 49.38M | 50.08M | 49.94M | 126.28M | 12.03M | 196.34M | 91.37M | — | — |
| Receivables | 57.02M | 34.90M | 44.06M | 40.29M | 28.55M | 26.38M | 12.10M | 5.42M | — |
| Inventory | 28.31M | 24.08M | 32.06M | 39.31M | 31.80M | 12.29M | 7.33M | 6.03M | — |
| Total Current Assets | 332.97M | 346.78M | 424.26M | 596.48M | 546.50M | 334.87M | 160.13M | 95.67M | — |
| Property, Plant & Equipment | 102.28M | 102.52M | 131.83M | 139.44M | 44.12M | 25.47M | 20.84M | 12.33M | — |
| Goodwill | 82.19M | 85.81M | 85.81M | 85.81M | 22.43M | 1.14M | 1.14M | 1.14M | — |
| Intangible Assets | 13.43M | 14.48M | 54.48M | 59.74M | 18.26M | 307.00K | 508.00K | 712.00K | — |
| Long-Term Investments | — | — | — | — | 0 | — | — | — | — |
| Total Assets | 641.86M | 614.32M | 776.40M | 961.38M | 702.10M | 398.88M | 186.99M | 115.79M | — |
| Accounts Payable | 11.09M | 1.63M | 14.05M | 20.09M | 14.90M | 4.83M | 9.76M | 7.53M | — |
| Short-Term Debt | — | — | — | 0 | 1.55M | 3.33M | 3.33M | 2.50M | — |
| Total Current Liabilities | 91.41M | 71.01M | 73.32M | 90.66M | 63.05M | 36.03M | 30.35M | 18.54M | — |
| Long-Term Debt | — | — | — | — | — | 1.40M | 4.40M | 7.22M | — |
| Total Liabilities | 168.90M | 141.63M | 152.97M | 171.99M | 121.28M | 62.62M | 34.91M | 26.73M | — |
| Shareholders' Equity | 472.96M | 472.69M | 623.43M | 789.38M | 580.82M | 336.26M | 152.08M | -201.42M | -133.36M |
| Retained Earnings | -1.32B | -1.24B | -1.03B | -828.42M | -610.55M | -458.45M | -318.52M | -210.85M | — |
| Total Debt | — | — | — | 0 | 1.55M | 4.74M | 7.73M | 9.72M | — |
| Net Cash (Debt) | 232.43M | 276.40M | 336.41M | 504.97M | 476.31M | 285.27M | 130.37M | 71.04M | 31.23M |
| Shares Outstanding | 60.63M | 58.88M | 57.56M | 56.52M | 49.50M | 45.08M | 32.87M | 3.21M | — |
This table shows 9 annual periods of Twist Bioscience's balance sheet, from FY 2025 back to FY 2017, across 20 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow TWST's reporting calendar. What is a balance sheet?